Mariann D Churchwell

Summary

Affiliation: University of Toledo
Country: USA

Publications

  1. ncbi Daptomycin clearance during modeled continuous renal replacement therapy
    Mariann D Churchwell
    The University of Toledo, College of Pharmacy, Department of Pharmacy Practice, Toledo, Ohio, USA
    Blood Purif 24:548-54. 2006
  2. ncbi Trace element removal during in vitro and in vivo continuous haemodialysis
    Mariann D Churchwell
    Department of Pharmacy Practice, University of Toledo College of Pharmacy, 2801 W Bancroft MS 609, Toledo, OH 43606, USA
    Nephrol Dial Transplant 22:2970-7. 2007
  3. ncbi Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis
    Mariann D Churchwell
    1Department of Pharmacy Practice, University of Toledo College of Pharmacy, Toledo, OH 43606 3360, USA
    Nephrol Dial Transplant 24:231-8. 2009
  4. ncbi Use of an in vitro model of renal replacement therapy systems to estimate extracorporeal drug removal
    Mariann D Churchwell
    University of Toledo College of Pharmacy and Pharmaceutical Sciences, 3000 Arlington Avenue, MS 1013, Toledo, OH, USA
    J Clin Pharmacol 52:35S-44S. 2012
  5. ncbi Drug dosing during continuous renal replacement therapy
    Mariann D Churchwell
    Department of Pharmacy Practice, University of Toledo, College of Pharmacy, Toledo, OH, USA
    Semin Dial 22:185-8. 2009
  6. ncbi Vibration enhances clearance of solutes with varying molecular weights during in vitro hemodialysis
    Bruce A Mueller
    Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 1065, USA
    ASAIO J 59:140-4. 2013
  7. ncbi Selected pharmacokinetic issues in patients with chronic kidney disease
    Mariann D Churchwell
    Department of Pharmacy Practice, University of Toledo College of Pharmacy, Toledo, Ohio, USA
    Blood Purif 25:133-8. 2007

Detail Information

Publications7

  1. ncbi Daptomycin clearance during modeled continuous renal replacement therapy
    Mariann D Churchwell
    The University of Toledo, College of Pharmacy, Department of Pharmacy Practice, Toledo, Ohio, USA
    Blood Purif 24:548-54. 2006
    ..Pharmacotherapy in critically ill patients receiving continuous renal replacement therapies (CRRT) is challenging due to the lack of published information to base dosing regimens...
  2. ncbi Trace element removal during in vitro and in vivo continuous haemodialysis
    Mariann D Churchwell
    Department of Pharmacy Practice, University of Toledo College of Pharmacy, 2801 W Bancroft MS 609, Toledo, OH 43606, USA
    Nephrol Dial Transplant 22:2970-7. 2007
    ..Our understanding of trace element CRRT clearance has been limited by poor assay sensitivity. The development of inductively coupled plasma mass spectrometry (ICP-MS) allows for the measurement of CRRT trace element removal...
  3. ncbi Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis
    Mariann D Churchwell
    1Department of Pharmacy Practice, University of Toledo College of Pharmacy, Toledo, OH 43606 3360, USA
    Nephrol Dial Transplant 24:231-8. 2009
    ..We investigated whether the addition of albumin to dialysate affects dialytic clearance of VPA, CBZ and PHT...
  4. ncbi Use of an in vitro model of renal replacement therapy systems to estimate extracorporeal drug removal
    Mariann D Churchwell
    University of Toledo College of Pharmacy and Pharmaceutical Sciences, 3000 Arlington Avenue, MS 1013, Toledo, OH, USA
    J Clin Pharmacol 52:35S-44S. 2012
    ..This review describes in vitro renal replacement therapy models and compares the findings of several in vitro and in vivo studies...
  5. ncbi Drug dosing during continuous renal replacement therapy
    Mariann D Churchwell
    Department of Pharmacy Practice, University of Toledo, College of Pharmacy, Toledo, OH, USA
    Semin Dial 22:185-8. 2009
    ..This drug dosing review will highlight factors that clinicians should consider when determining a pharmacotherapy regimen for a patient receiving CRRT...
  6. ncbi Vibration enhances clearance of solutes with varying molecular weights during in vitro hemodialysis
    Bruce A Mueller
    Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 1065, USA
    ASAIO J 59:140-4. 2013
    ..The addition of vibration during dialysis increased transmembrane clearance for solutes with molecular weights of 60-1450 Daltons...
  7. ncbi Selected pharmacokinetic issues in patients with chronic kidney disease
    Mariann D Churchwell
    Department of Pharmacy Practice, University of Toledo College of Pharmacy, Toledo, Ohio, USA
    Blood Purif 25:133-8. 2007
    ..The likelihood of an adverse drug reaction increases with each medication added to these patients' daily regimen. In this article we discuss selected pharmacokinetic issues unique to CKD patients...